Canine CA50 antibody and antigen (recombinant protein)

Diagnostic anti-Canine CA50 antibodies pairs and antigen for animal health (animal Dog/Canine pancreatic and colorectal cancer) testing in ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT

Target products collectionGo to Neurodegenerative diseases diagnostics products collection >>


Product information

Catalog No. Description US $ Price (per mg)
GMP-CAN-CA50-Ag01 Recombinant Canine CA50 protein 3090
GMP-CAN-CA50-Ab01 Anti-Canine CA50 mouse monoclonal antibody (mAb) 1953
GMP-CAN-CA50-Ab02 Anti-Canine CA50 mouse monoclonal antibody (mAb) 1953
GMP-CAN-CA50-Ab03 Anti-Canine CA50 human monoclonal antibody (mAb) 1953
GMP-CAN-CA50-Ab04 Anti-Canine CA50 human monoclonal antibody (mAb) 1953

Size: 1mg | 10mg | 100mg



Product Description

Cat No. of Products GMP-CAN-CA50-Ag01
Product Name Recombinant Canine CA50 protein
Target/Biomarker Canine Carbohydrate Antigen 50 (AIV-A H9N2 subtype)
Expression platform E.coli
Isotypes Recombinant Antigen
Bioactivity validation Anti-Canine Carbohydrate Antigen 50 antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in AIV-A H9N2 subtype level test of animal Dog/Canine with pancreatic and colorectal cancer.
Tag His
Products description Recombinant Canine CA50 protein was expressed in E.coli - based prokaryotic cell expression system and is expressed with 6 HIS tag at the C-terminus.
Purity Purity: ≥95% (SDS-PAGE)
Application Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Cat No. of Products GMP-CAN-CA50-Ab01, GMP-CAN-CA50-Ab02
Product Name Anti-Canine CA50 mouse monoclonal antibody (mAb)
Target/Biomarker Canine Carbohydrate Antigen 50 (AIV-A H9N2 subtype)
Expression platform CHO
Isotypes Mouse IgG
Bioactivity validation Recombinant Canine Carbohydrate Antigen 50 antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-AIV-A H9N2 subtype antibodies in AIV-A H9N2 subtype level test of animal Dog/Canine with pancreatic and colorectal cancer.
Tag mFc
Products description Anti-Canine CA50 mouse monoclonal antibody (mAb) is a monoclonal antibody produced by CHO technology. The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-AIV-A H9N2 subtype antibodies.
Purity Purity: ≥95% (SDS-PAGE)
Application Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Cat No. of Products GMP-CAN-CA50-Ab03, GMP-CAN-CA50-Ab04
Product Name Anti-Canine CA50 human monoclonal antibody (mAb)
Target/Biomarker Canine Carbohydrate Antigen 50 (AIV-A H9N2 subtype)
Expression platform CHO
Isotypes Human IgG1
Bioactivity validation Recombinant Canine Carbohydrate Antigen 50 antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-AIV-A H9N2 subtype antibodies in AIV-A H9N2 subtype level test of animal Dog/Canine with pancreatic and colorectal cancer.
Tag hFc
Products description Anti-Canine CA50 human monoclonal antibody (mAb) is a monoclonal antibody produced by CHO technology. The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-AIV-A H9N2 subtype antibodies.
Purity Purity: ≥95% (SDS-PAGE)
Application Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Validation Data


    Click to get more Data / Case study about the product.



    Target/Biomarker information

    Carbohydrate Antigen 50 (CA50) is a glycoprotein biomarker with vital implications in canine health, particularly in the sphere of cancer diagnosis and monitoring. This biomarker is associated with several types of cancer in dogs, with a significant focus on those affecting the gastrointestinal and pancreatic regions. Structurally, CA50 is classified as a carbohydrate antigen, featuring a protein core with attached carbohydrate molecules. In the context of canine health, CA50 assumes significance as a diagnostic tool for the early detection of cancer. Cancers affecting the gastrointestinal and pancreatic regions can be insidious, often presenting with subtle or nonspecific clinical signs. CA50 blood tests offer a non-invasive and highly sensitive means of identifying these malignancies, enabling prompt intervention and potentially improving treatment outcomes. CA50 levels in a dog's bloodstream become elevated when cancer cells, particularly those found in gastrointestinal and pancreatic cancers, produce and release this glycoprotein. As a result, CA50 serves as a biomarker that can be readily detected and quantified through blood tests.



    About GDU


    GDU

    GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.

    Comments


    No comments yet.

    Leave a comment